FHIP1A divergent transcript (FHIP1A-DT)

FHIP1A divergent transcript (FHIP1A-DT, also known as FAM160A1-DT, RP11-610P16.1, or FHIP1A divergent transcript) is a **long non-coding RNA (lncRNA) gene**. It is categorized as a divergent transcript relative to the FHIP1A gene, meaning its transcription start site is close but on the opposite DNA strand to the coding gene FHIP1A[1][3]. FHIP1A-DT is listed in gene databases as a non-protein-coding RNA, and there are no well-established biological functions, disease associations, or therapeutic strategies targeting this molecule. Like many lncRNAs, it may have potential regulatory functions in gene expression, but its specific role in human biology and disease remains poorly characterized[3][1]. FHIP1A, the associated protein-coding gene, has been studied in the context of perinuclear protein localization and some disease associations, but these are not mapped to the divergent transcript[2][6]. FHIP1A-DT has not been reported as a therapeutic target or biomarker in clinical or preclinical contexts. **Notes:** - FHIP1A-DT is not a receptor, enzyme, transporter, or other conventional therapeutic target class, and there is no evidence that it has been explored as a direct drug target, nor that it interacts with known therapeutic agents. - Most available data identify it as a long non-coding RNA with little to no functional annotation in current databases. - There are no major safety, efficacy, or biomarker-related entries for this lncRNA. If you require a structured form for entity extraction, the above fields provide canonical, normalized values according to the conventions requested.

Other names

FAM160A1-DTFAM160A1 divergent transcriptRP11-610P16.1FHIP1A-DT

Not applicable